CompletedPhase 2NCT02707562
Study of GLPG1837 in Subjects With Cystic Fibrosis (G551D Mutation)
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Galapagos NV
- Principal Investigator
- Olivier Van de Steen, MD, MBAGalapagos NV
- Intervention
- GLPG1837 dose 1(drug)
- Enrollment
- 26 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2016
Study locations (16)
- Royal Adelaide Hospital, Adelaide, Australia
- The Prince Charles Hospital, Chermside, Australia
- Monash Medical Centre, Clayton, Australia
- Sir Charles Gairdner Hospital, Nedlands, Australia
- Mater Adult Hospital, South Brisbane, Australia
- Fakultni nemocnice v Motole, Prague, Czechia
- Charité Universitätsmedizin Berlin, Berlin, Germany
- Universitätsklinkikum Koeln, Cologne, Germany
- Uniklinik Carl-Gustav-Carus, Dresden, Germany
- Lungenheilkunde München-Pasing, München, Germany
- Beamont Hospital, Dublin, Ireland
- St. Vincent's University Hospital, Dublin, Ireland
- Queen Elizabeth University Hospital, Glasgow, United Kingdom
- Liverpool Heart and Chest Hospital, Liverpool, United Kingdom
- Royal Brompton Hospital, London, United Kingdom
- +1 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02707562 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT04530383Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel FunctionUniversity of Kansas Medical Center
- RECRUITINGPHASE2NCT07450547Phase 2 Study to Assess the Safety and Efficacy of ANG003Anagram Therapeutics, Inc.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.